Non-invasive Continuous Cardiac Output Monitoring in Preterm Infants Study
Launched by IMPERIAL COLLEGE HEALTHCARE NHS TRUST · Aug 20, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Non-invasive Continuous Cardiac Output Monitoring in Preterm Infants Study is looking at how we can safely and effectively monitor the heart function in newborn babies, especially those born early (preterm). The researchers want to see if a non-invasive method—meaning it doesn’t involve needles or surgery—can continuously measure the amount of blood the heart pumps out. They will also examine how this measurement changes when infants receive extra fluids or medications that help the heart work better.
To participate in this study, infants must be healthy term babies in the hospital within their first 72 hours or preterm babies admitted to the neonatal unit. Parents will need to give written consent for their babies to be part of the study. Unfortunately, babies with serious birth defects or those who are older than 12 hours, as well as those with very delicate skin, cannot participate. If enrolled, families can expect regular monitoring of their baby’s heart function without any invasive procedures, helping doctors better understand how to care for these vulnerable infants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy term infants in postnatal ward (within the first 72 hours of age)
- • Term and Preterm infants (including those with FGR) admitted to the neonatal unit
- • Written informed parental consent (prospective for postnatal ward and retrospective for babies admitted to the neonatal units)
- Exclusion Criteria:
- • Antenatal or postnatal diagnosis of severe congenital anomaly
- • Infants with no realistic chance of survival
- • Infants who are \>12 hours of age
- • Infants with fragile skin not permitting skin probe placement
About Imperial College Healthcare Nhs Trust
Imperial College Healthcare NHS Trust is a leading healthcare provider in London, renowned for its commitment to delivering high-quality patient care and advancing medical research. As an integral part of the NHS, the Trust encompasses a range of specialized services and facilities, including multiple hospitals and outpatient centers, where it fosters a collaborative environment for clinical trials. With a focus on innovation and excellence, Imperial College Healthcare NHS Trust supports a diverse portfolio of clinical research initiatives aimed at translating scientific discoveries into effective treatments and improving health outcomes for patients. Its partnership with Imperial College London enhances its capabilities in cutting-edge research, making it a pivotal institution in the landscape of healthcare and clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Jayanta Banerjee
Principal Investigator
Neonatal consultant
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials